about
Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migrationCdc42 in oncogenic transformation, invasion, and tumorigenesisR-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and MetastasisCooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implicationsStarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasionDeleted in liver cancer protein family in human malignancies (Review)Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Identification of potential small molecule binding pockets on Rho family GTPasesGrp78 promotes the invasion of hepatocellular carcinoma.Extracellular HSP70/HSP70-PCs regulate hepatocarcinoma cell migration and invasion via RhoAEstablishment of epithelial polarity--GEF who's minding the GAP?Netrin-4 induces lymphangiogenesis in vivoROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell lineRho/ROCK signaling in motility and metastasis of gastric cancerTransgelin 2 participates in lovastatin-induced anti-angiogenic effects in endothelial cells through a phosphorylated myosin light chain-related mechanism.Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesDownregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells.MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA.Role of RHOT1 on migration and proliferation of pancreatic cancer.Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma.The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosisTight junctions: a barrier to the initiation and progression of breast cancer?Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis.Rho GTPases modulate malignant transformation of tumor cells.Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.Lentivirus-mediated knockdown of P27RF-Rho inhibits hepatocellular carcinoma cell growthGas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis.Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma.
P2860
Q24297486-49ACF59F-0A02-4054-8AC7-1BC24F045D9EQ28236231-22E5D49D-DBB9-45AB-8338-D3C55FAC080BQ28265491-89E3B535-E5E9-4506-93E3-A86E92BC752DQ28384501-324BC646-B48C-4620-B0EB-0836EBA2D52FQ28386295-D2BFA4C2-9183-4E6F-A85D-169C4AE083FDQ28387011-FA9DC6AB-3E23-4F51-AA84-7EE2538E50A7Q28394917-B59228EE-7EB5-42DA-BD1D-82E9493819E8Q28481320-F16048B1-904C-404E-BFB4-FBA425A79775Q33524918-228DCEDF-A05B-4865-A901-5C0F055AA69FQ33598186-9AD9392E-1AE0-46DB-8A2C-5D5B4CE9F1A1Q33980507-305022BF-445A-4917-B083-8BBC6CD1E85EQ33985154-E55966D2-57EA-4BFE-9C82-AB92A9539B3EQ34215809-1F648BBC-1915-4E31-BEC6-C0F67EDFB350Q34326599-05930493-C7A5-4AC3-AD1F-5D1BA7152006Q34441557-B3FD655B-42AA-4C78-BEFB-7F29F8A1E3ECQ34993023-71DA0254-77BA-4DF7-864D-A0774DA59371Q35067883-3F3DA460-DA5E-4030-9400-6EAF81EF7D9EQ35200832-F9184861-4AE4-4F57-92EF-AD22B6D14833Q35758011-AF6F0888-F557-451F-86DD-3DD732F8F988Q36202958-242A4577-5015-447C-B37F-3D3132B7356EQ36230751-02E01539-F52C-4D20-B8C9-522DDB28D56CQ37295516-BB902209-9761-4280-91CA-0D62780FDCD5Q37420725-BB990FDE-5AFE-453A-A8F1-4EBC8055BC4FQ37580201-33D723D0-0C9B-4A9E-9F89-4F387CD99068Q37706317-776AA107-57AD-4A45-A711-F89BF7D6F5A7Q38230951-938956BD-2380-4C41-8D5A-005F7916A42AQ38854124-CC841958-ED05-4BFD-B937-2E84368F9367Q39175895-1DDD03DE-63E0-44A8-A67F-B3F93E2E45CDQ41824679-C8885997-D8D7-4458-8064-6175BAE75CB2Q42918512-AC1D29AB-4F40-4514-9072-BB35DB4E34B0Q42952495-2B501FF7-968C-4792-A344-8677277549AE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rho GTPases in hepatocellular carcinoma.
@en
Rho GTPases in hepatocellular carcinoma.
@nl
type
label
Rho GTPases in hepatocellular carcinoma.
@en
Rho GTPases in hepatocellular carcinoma.
@nl
prefLabel
Rho GTPases in hepatocellular carcinoma.
@en
Rho GTPases in hepatocellular carcinoma.
@nl
P2093
P1476
Rho GTPases in hepatocellular carcinoma.
@en
P2093
Aurélien Bidaud
Florence Grise
Violaine Moreau
P304
P356
10.1016/J.BBCAN.2008.12.003
P407
P577
2009-01-07T00:00:00Z